Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Resistant Depression (TRD)”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07189689
What this trial is testing

Mental Health Mission Mood Disorder Cohort Study

Who this might be right for
Depression - Major Depressive DisorderDepression BipolarTreatment Resistant Depression
University of Oxford 2,000
Testing effectiveness (Phase 2)Study completedNCT05113771
What this trial is testing

A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

Who this might be right for
Treatment Resistant Depression
Denovo Biopharma LLC 197
Not applicableLooking for participantsNCT06812923
What this trial is testing

TACS on High-inflammatory and Refractory Depression

Who this might be right for
Treatment Resistant Depression (TRD)Inflammation
Tianjin Anding Hospital 52
Not applicableLooking for participantsNCT07543328
What this trial is testing

Transcranial Photobiomodulation (tPBM) for Somatic Symptoms in Treatment-Resistant Depression

Who this might be right for
Treatment-resistant Depression (TRD)Major Depression Disorder
Taipei Veterans General Hospital, Taiwan 40
Not applicableStudy completedNCT00320372
What this trial is testing

Treatment-Resistant Depression Registry

Who this might be right for
Major Depressive Disorder
Cyberonics, Inc. 795
Large-scale testing (Phase 3)Study completedNCT02741791
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder

Who this might be right for
Treatment Resistant Major Depressive Disorder
Axsome Therapeutics, Inc. 312
Testing effectiveness (Phase 2)Study completedNCT01246908
What this trial is testing

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
CeNeRx BioPharma Inc. 360
Testing effectiveness (Phase 2)Study completedNCT00768430
What this trial is testing

Optimization of IV Ketamine for Treatment Resistant Depression

Who this might be right for
Major Depressive Disorder (MDD)Treatment Resistant Depression (TRD)
Baylor College of Medicine 73
Not applicableStudy completedNCT05137938
What this trial is testing

Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)

Who this might be right for
Depression
Centre for Addiction and Mental Health 25
Testing effectiveness (Phase 2)Ended earlyNCT01913535
What this trial is testing

Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression
Massachusetts General Hospital 8
Not applicableLooking for participantsNCT07563868
What this trial is testing

Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression (TRD)
Massachusetts General Hospital 20
Not applicableUnknownNCT05008939
What this trial is testing

Sevoflurane for Treatment-Resistant Depression

Who this might be right for
Depressive Disorder, Treatment-ResistantDepressive Disorder, Major
Shanghai First Maternity and Infant Hospital 15
Not applicableLooking for participantsNCT03887715
What this trial is testing

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression
LivaNova 6,800
Not applicableStudy completedNCT01304147
What this trial is testing

Intranasal Ketamine in Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
James Murrough 20
Not applicableStudy completedNCT06166082
What this trial is testing

Intensive Accelerated iTBS for the Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression
Changping Laboratory 130
Testing effectiveness (Phase 2)Study completedNCT01920555
What this trial is testing

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

Who this might be right for
Treatment Resistant Depression
Massachusetts General Hospital 99
Not applicableStudy completedNCT01162434
What this trial is testing

Brain MRI (Magnetic Resonance Imaging) Scans of Patients With Treatment Resistant Depression (TRD) and Healthy Controls

Who this might be right for
Mental Disorders
University of Bristol 21
Not applicableActive Not RecruitingNCT01798407
What this trial is testing

DBS of the Lateral Habenula in Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Major Depressive Disorder
Wayne Goodman MD 6
Post-approval studies (Phase 4)Study completedNCT07053345
What this trial is testing

Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
Janssen Korea, Ltd., Korea 47
Testing effectiveness (Phase 2)UnknownNCT04433858
What this trial is testing

An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)

Who this might be right for
Treatment Resistant Depression
Sheppard Pratt Health System 27
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation